SETON Healthcare, owners of the Cupal pharmaceuticals plant in Blackburn, has seen pretax profits soar by 45 per cent.
In the six months to August 31, the group enjoyed a 39 per cent leap in sales to £49 million with profits up to £7.9 million.
And chairman Norman Stoller said prospects for the second half of the year were promising.
"The group achieved strong sales growth in the first half and we expect the underlying trend to remain positive." He said the Blackburn site had continued to play a vital role within the group.
A new automated liquid filling line and computerised manufacturing line have recently been installed.
Seton, the fourth largest supplier of over the counter products to UK pharmacies, saw sales rise in all divisions, including a 38 per cent increase in exports.
Shareholders will receive an interim dividend of 2.7p per share.
Converted for the new archive on 14 July 2000. Some images and formatting may have been lost in the conversion.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article